Bictegravir-Tenofovir alafenamide-Emtricitabine Biktarvy
Darunavir-Cobicistat-Tenofovir alafenamide-Emtricitabine Symtuza
Dolutegravir-Abacavir-Lamivudine Triumeq
Dolutegravir-Lamivudine Dovato
Dolutegravir-Rilpivirine Juluca
Doravirine-Tenofovir DF-Lamivudine Delstrigo
Efavirenz-Tenofovir DF-Emtricitabine Atripla
Elvitegravir-Cobicistat-Tenofovir alafenamide-Emtricitabine Genvoya
Elvitegravir-Cobicistat-Tenofovir DF-Emtricitabine Stribild
Rilpivirine-Tenofovir alafenamide-Emtricitabine Odefsey
Rilpivirine-Tenofovir DF-Emtricitabine Complera
Fostemsavir Rukobia
Ibalizumab Trogarzo
Maraviroc Selzentry
Dolutegravir Tivicay
Raltegravir Isentress
Tenofovir alafenamide-Emtricitabine Descovy
Tenofovir DF-Emtricitabine Truvada and Multiple Generics
Doravirine Pifeltro
Efavirenz Sustiva
Etravirine Intelence
Rilpivirine EdurantAntiretroviral Therapy
You are just a few steps away from free CE credits!
1
Sign in or Register
A free account is required.
2
Study the Material
An entire Cc section, or just a few topics at a time.
3
Take the CE Quiz
5 questions covering the topics in each Cc section.
4
Claim CE Credit
Free CNE and Free CME available!
Section Navigation
Section Navigation
- Lesson 3 Overview
Drug Interactions with Antiretroviral Medications - 0%Topic 1
OverviewActivities- 0%Topic 2
Acid Suppressive Therapy and SupplementsActivities- 0%Topic 3
AntimycobacterialsActivities- 0%Topic 4
Cardiovascular MedicationsActivities- 0%Topic 5
CorticosteroidsActivities- 0%Topic 6
Hepatitis C TreatmentsActivities- 0%Topic 7
HMG-CoA Reductase Inhibitors (Statins)Activities- 0%Topic 8
Mental Health MedicationsActivities- 0%Topic 9
Opioid Agonist TherapyActivities- 0%Topic 10
Oral Anticoagulants and Antiplatelet TherapyActivities- 0%Topic 11
Phosphodiesterase Type 5 (PDE5) InhibitorsActivities- 0%Topic 12
Miscellaneous InteractionsDrug Interactions with Antiretroviral Medications Overview
About this Lesson
Last Updated: February 3rd, 2025CNE/CME Continuing Education
This lesson qualifies for:- 1.5 CME AMA PRA Category 1 Credits™, or
- 1.5 CNE contact hours and 1.5 CE contact hours (qualifies for pharmacology CE for advanced practice nurses)
CNE and CME Origination: June 1st, 2017CNE and CME Review: September 1st, 2023CNE and CME Expiration: August 31st, 2026 (3rd Edition)
View CE NoticesSteps to Acquire CE for this Lesson:
3Print CE Certificate
Obtain proof of CE3rd Edition
This is a substantial revision of the original Lesson. The previous edition was titled Drug Interactions with Antiretroviral Medications and available until September 1st, 2023.Learning Objectives
- Explain the difference between pharmacokinetics and pharmacodynamics
- Access resources for checking drug interactions that involve antiretroviral medications
- Identify commonly used antiretroviral medications that often cause significant drug interactions
- Discuss how antiretroviral medications can increase or decrease levels of some medications when coadministered
- Describe potential drug interactions between antiretroviral medications and medications commonly used to treat comorbid conditions
Lesson Contributors
Authors
John J. Faragon, PharmD, BCPS, AAHIV-PJohn J. Faragon, PharmD, BCPS
Pharmacist, Albany Medical Center
Regional Pharmacy Director
Northeast/Caribbean AETCDisclosures:Consulting fees: ViiV Healthcare
Speakers Bureau: Gilead SciencesThe relevant financial relationship was mitigated.Jehan Z. Budak, MDJehan Z. Budak, MD
Associate Professor of Medicine
Division of Allergy & Infectious Diseases
University of WashingtonDisclosures:NoneReviewers
David H. Spach, MDDavid H. Spach, MD
Professor of Medicine
Division of Allergy & Infectious Diseases
University of WashingtonDisclosures:NoneBrian R. Wood, MDBrian R. Wood, MD
Professor of Medicine
Division of Allergy & Infectious Diseases
University of WashingtonDisclosures:NoneLesson Plan
Quick Reference View
A single document for easy access to every topic in the self-study modules.
PDF version also available.
No sign-in required for Quick Reference
Question Bank
Interactive board-review style questions about Epidemiology of HIV.
CNE/CME CME+MOC credits and CNE contact hours available.
Requires sign-in for CE credit or Certificates
Funded byHealth Resources and Services Administration (HRSA)Created at University of WashingtonAn AETC ProgramPart of IDEA PlatformCME provided byUniversity of Alabama BirminghamCNE approved byOregon Nurses AssociationCopyright © 2025 National HIV CurriculumThe Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS) provided financial support for this website. The award provided 100% of total costs and totaled $1,172,994. The contents are those of the author. They may not reflect the policies of HRSA, HHS, or the U.S. Government.Since you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.
Current Version: nhivc-master-d52d2330-2025-09-05-201745 - 0%Topic 2